NEW YORK (Reuters Health) - Only a small number of U.S. women at high risk of breast cancer have chosen to use the drug tamoxifen to lower that risk, according to a study published Monday.
NEW YORK (Reuters Health) - Only a small number of U.S. women at high risk of breast cancer have chosen to use the drug tamoxifen to lower that risk, according to a study published Monday.
